{"id":17868,"date":"2021-03-12T08:13:19","date_gmt":"2021-03-12T13:13:19","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=17868"},"modified":"2021-03-12T08:13:19","modified_gmt":"2021-03-12T13:13:19","slug":"five-set-terms-for-next-week-filings-continue-to-flow-in","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/five-set-terms-for-next-week-filings-continue-to-flow-in\/","title":{"rendered":"Five Set Terms for Next Week; Filings Continue to flow in"},"content":{"rendered":"<p><!--more--><\/p>\n<p><span style=\"text-decoration: underline;\"><strong>NEW FILINGS<\/strong><\/span><\/p>\n<p>Company: Alkami Technology, Inc..<br \/>\nSymbol: ALKT<br \/>\nDescription: Alkami is a cloud-based digital banking platform.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Goldman Sachs, JP Morgan, Barclays<br \/>\nCo-Manager(s): Citigroup, William Blair, JMP Securities, KeyBanc Capital, Needham<br \/>\nFiled: 3-10-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Global-E Online Ltd.<br \/>\nSymbol: GLBE<br \/>\nDescription: They have built the world\u2019s leading platform to enable and accelerate global, direct-to-consumer (\u201cD2C\u201d) cross-border e-commerce.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Goldman Sachs, Morgan Stanley, Jefferies<br \/>\nCo-Manager(s): Piper Sandler, JMP Securities, KeyBanc Capital, Raymond James<br \/>\nFiled: 3-8-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Frontier Group Holdings<br \/>\nSymbol: FRNT<br \/>\nDescription: Frontier Airlines is an ultra low-cost carrier whose business strategy is focused on Low Fares Done Right\u00ae.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Citigroup, Barclays, Deutsche Bank Securities, Morgan Stanley, Evercore ISI, BofA Securities, Goldman Sachs, JP Morgan, Nomura, UBS<br \/>\nCo-Manager(s): Cowen, Raymond James<br \/>\nFiled: 3-8-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Design Therapeutics, Inc<br \/>\nSymbol: DSGN<br \/>\nDescription: They are a preclinical-stage biopharmaceutical company pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs), that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Goldman Sachs, SVB Leerink, Piper Sandler<br \/>\nFiled: 3-5-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Agiliti, Inc<br \/>\nSymbol: AGTI<br \/>\nDescription: Agiliti is an essential service provider to the U.S. healthcare industry with solutions that help support a more efficient, safe and sustainable healthcare delivery system.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): BofA Securities, Goldman Sachs, Morgan Stanley, BMO Capital Market, Citigroup, Jefferies, UBS Investment Bank<br \/>\nCo-Manager: KeyBanc Capital, Raymond James, MUFG, SMBC Nikko, Mischler Financial Group, Siebert Williams Shank<br \/>\nFiled: 3-5-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Coursera, Inc..<br \/>\nSymbol: COUR<br \/>\nDescription: They have built a global platform connecting learners, educators, and institutions, providing world-class educational content that is affordable, accessible, and relevant.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Morgan Stanley, Goldman Sachs, Citigroup, UBS Investment Bank<br \/>\nCo-Manager(s): KeyBanc Capital, Raymond James, Stifel, Truist Securities, William Blair, DA Davidson, Needham &amp; Co., Loop Capital, Telsey Advisory Group<br \/>\nFiled: 3-5-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Edgewise Therapeutics, Inc.<br \/>\nSymbol: EWTX<br \/>\nDescription: They aim to build a leading, global biopharmaceutical company focused on rare diseases involving muscle in order to develop transformative precision medicines to treat and possibly cure these (muscle) disorders.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): JP Morgan, Goldman Sachs, SVB Leerink<br \/>\nCo-Manager: Wedbush PacGrow<br \/>\nFiled: 3-5-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Ikena Oncology, Inc.<br \/>\nSymbol: IKNA<br \/>\nDescription: They are a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Jefferies, Cowen, Credit Suisse, William Blair<br \/>\nFiled: 3-5-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Zhihu, Inc.<br \/>\nSymbol: ZH<br \/>\nDescription: Zhihu is an iconic online content community where people come to seek inspiration, find solutions, make decisions, and have fun.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Credit Suisse, Goldman Sachs, JP Morgan (Alphabetical order)<br \/>\nFiled: 3-5-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>TERMS ADDED<\/strong><\/span><\/p>\n<p>Company: The Duckhorn Portfolio Inc<br \/>\nSymbol: NAPA<br \/>\nShares: 20 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nMarket Cap: $1.6b-$1.84b<br \/>\nTrade Date: Thursday, 3\/18<br \/>\nDescription: They are the premier scaled producer of luxury wines in North America.<br \/>\nUnderwriter(s): J.P. Morgan, Credit Suisse, Jefferies<br \/>\nCo-Manager(s): Barclays, BofA Securities, Citigroup, Evercore ISI, RBC Capital Markets, Academy Securities, Ramirez &amp; Co., Siebert Williams Shank<br \/>\nTerms Added: 3-10-21<\/p>\n<p>Company: Gain Therapeutics, Inc.<br \/>\nSymbol: GANX<br \/>\nShares: 3.6 million<br \/>\nPrice Range: $10.00-$12.00<br \/>\nMarket Cap: $114m-$136m<br \/>\nTrade Date: Thursday, 3\/18<br \/>\nDescription: They are a development stage biotechnology company developing novel therapeutics to treat diseases caused by protein misfolding, with an initial focus on lysosomal storage disorders (\u201cLSDs\u201d), including rare genetic diseases and neurological disorders.<br \/>\nUnderwriter(s): BTIG, Oppenheimer<br \/>\nCo-Manager(s): National Securities<br \/>\nTerms Added: 3-10-21<\/p>\n<p>Company: Vine Energy, Inc.<br \/>\nSymbol: VEI<br \/>\nShares: 18.75 million<br \/>\nPrice Range: $16.00-$19.00<br \/>\nMarket Cap: $1.1b-$1.3b<br \/>\nTrade Date: Thursday, 3\/18<br \/>\nDescription: They are an energy company focused on the development of natural gas properties in the stacked Haynesville and Mid-Bossier shale plays in the Haynesville Basin of Northwest Louisiana.<br \/>\nUnderwriter(s): Citigroup, Credit Suisse, Morgan Stanley, BofA Securities, Barclays, RBC Capital<br \/>\nTerms Added: 3-9-21<br \/>\nPE Backed by Blackstone Group<\/p>\n<p>Company: Sun Country Airlines Holdings, Inc.<br \/>\nSymbol: SNCY<br \/>\nShares: 9.1 million<br \/>\nPrice Range: $21.00-$23.00<br \/>\nMarket Cap: $1.2b-$1.3b<br \/>\nTrade Date: Wednesday, 3\/17<br \/>\nDescription: Sun Country Airlines is a new breed of hybrid low-cost air carrier that dynamically deploys shared resources across our synergistic scheduled service, charter and cargo businesses.<br \/>\nUnderwriter(s): Barclays, Morgan Stanley, Deutsche Bank Securities, Goldman Sachs, Nomura<br \/>\nCo-Manager(s): Apollo Global<br \/>\nTerms Added: 3-8-21<\/p>\n<p>Company: Olo, Inc.<br \/>\nSymbol: OLO<br \/>\nShares: 18 million<br \/>\nPrice Range: $16.00-$18.00<br \/>\nMarket Cap: $2.3b-$2.6b<br \/>\nTrade Date: Wednesday, 3\/17<br \/>\nDescription: Olo provides a leading cloud-based, on-demand commerce platform for multi-location restaurant brands.<br \/>\nUnderwriter(s): Goldman Sachs, JP Morgan, RBC Capital<br \/>\nCo-Manager(s): Piper Sandler, Stifel, Truist Securities, William Blair<br \/>\nTerms Added: 3-8-21<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":12986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[2058,1536],"tags":[],"class_list":["post-17868","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-spotlight","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/17868","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=17868"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/17868\/revisions"}],"predecessor-version":[{"id":17869,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/17868\/revisions\/17869"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media\/12986"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=17868"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=17868"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=17868"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}